Patent Assignment
Reel/Frame 025506/0253
Assignment of Assignor's Interest
Recorded: 2010-12-15
Pages: 4
Assignors
NEMUNAITIS, JOHN
Executed: 2010-04-01
RAO, DONALD
Executed: 2010-04-01
BRUNICARDI, F. CHARLES
Executed: 2010-04-20
Assignee
GRADALIS, INC.
2545 GOLDEN BEAR DRIVE, SUITE 110, CARROLLTON, TEXAS, 75006
Covered Property
(1)
Novel Therapeutic Rna Interference Technology Targeted to the Pdx-1 Oncogene in Pdx-1 Expressing Neuroendocrine Tumors
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 14, 2012
From: GRADALIS, INC.
To: BRUNICARDI, F. CHARLES
Reel/Frame 029295/0674 →
Assignment of Assignor's Interest
Nov 30, 2012
From: BRUNICARDI, F. CHARLES
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 029385/0753 →
Assignment of Assignor's Interest
May 6, 2015
From: GRADALIS, INC.
To: STRIKE BIO, INC.
Reel/Frame 035603/0731 →
Merger
May 3, 2018
From: STRIKE BIO, INC.
To: GRADALIS, INC.
Reel/Frame 045709/0406 →
Patent Security Agreement
Dec 20, 2019
From: GRADALIS, INC.
To: HC INNOVATIVE PARTNERS, LP, AS COLLATERAL AGENT
Reel/Frame 051396/0366 →